Showing results (691-700 of 1,185) with videos related to

Sort By:
Pageof 119
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|June 22, 2016
The biological response to orthopaedic implants for joint replacement: Part I: MetalsEmmanuel Gibon, Derek F Amanatullah, Florence Loi, et al.
The Journal of Arthroplasty|October 19, 2001
Measurement of perioperative flexion-extension mechanics of the knee jointN J Giori, K L Giori, S T Woolson, et al.
The Bone & Joint Journal|April 8, 2017
Total hip arthroplasty using a monobloc cementless femoral stem for patients with childhood Perthes' diseaseK H Lee, W-L Jo, Y C Ha, et al.
The Journal of Arthroplasty|January 24, 2017
Use of Cortical Strut Allograft After Extended Trochanteric Osteotomy in Revision Total Hip ArthroplastyChin Tat Lim, Derek F Amanatullah, James I Huddleston, et al.
Journal of Biomedical Materials Research. Part A|July 1, 2015
NF-κB decoy oligodeoxynucleotide inhibits wear particle-induced inflammation in a murine calvarial modelTaishi Sato, Jukka Pajarinen, Tzu-hua Lin, et al.
The Journal of Rheumatology|February 4, 2003
Intermittent hydrostatic pressure inhibits shear stress-induced nitric oxide release in human osteoarthritic chondrocytes in vitroMel S Lee, Michael C D Trindade, Takashi Ikenoue, et al.
Synapse (New York, N.Y.)|February 1, 1995
6 beta-[125iodo]-3, 14-dihydroxy-17-methyl-4, 5 alpha-epoxymorphinan ([125I]IOXY-AGO): a potent and selective radioligand for opioid mu receptorsH Xu, C B Goodman, J S Partilla, et al.
The Journal of Biological Chemistry|October 25, 1991
Phagocytic cell molecules that bind the collagen-like region of C1q. Involvement in the C1q-mediated enhancement of phagocytosisE N Guan, W H Burgess, S L Robinson, et al.
The Journal of Rheumatology|February 12, 2009
Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implantsYasunobu Tamaki, Yuya Takakubo, Kaoru Goto, et al.
Clinical Genitourinary Cancer|July 5, 2011
Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancerJason C Gonzales, Louis M Fink, Oscar B Goodman, et al.
Pageof 119